NCT01749410View on ClinicalTrials.gov

A Retrospective Study to Evaluate the Effectiveness and Benefit of onabotulinumtoxinA in Patients With Chronic Migraines

CompletedOBSERVATIONAL
Enrollment

33

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Chronic Migraine, Headaches
Interventions
BIOLOGICAL

onabotulinumtoxinA

Previous treatment with onabotulinumtoxinA for Chronic Migraine.

Trial Locations (1)

Unknown

Encinitas

Sponsors

Lead Sponsor

Allergan
All Listed Sponsors
lead

Allergan

INDUSTRY

NCT01749410 - A Retrospective Study to Evaluate the Effectiveness and Benefit of onabotulinumtoxinA in Patients With Chronic Migraines | Biotech Hunter | Biotech Hunter